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ABSTRACT 
 
Aim: To evaluate the antimicrobial activities of Pleurotus squarrosulus mushroom extracts on 
bacterial and fungal isolates. 
Study Design: Pleurotus squarrosulus was obtained from different sources in Umuahia North Local 
Government, Abia state, Nigeria and identified in the Department of botany, University of Nigeria, 
Nsukka. 
Place and Duration of Study: Antimicrobial activities of Pleurotus squarrosulus was carried out in 
the department of microbiology between January 2016 and August 2016  
Methodology: Pleurotus squarrosulus was extracted using ethanol, methanol and aqueous. 
Antimicrobial susceptibility tests were carried out by agar disc diffusion technique using National 
Committee of Clinical Laboratory Standard. Qualilative phytochemical analysis was carried out using 
standard methods. 
Results: Methanol, ethanol and aqueous extracts of Pleurotus squarrosulus were tested against E. 
coli, B. cereus, S. aureus, P. aeruginosa, C. albicans and C. glabrata. The different test 
microorganisms showed varied susceptibility to the test extracts. All the test organisms were 
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inhibited by methanol, ethanol and aqueous extract at varied concentrations ranging between 500 
mg/ml and 125 mg/ml. Statistically, inhibition of the antibacterial and antifungal control for the test 
organisms were significantly higher (P < 0.05) than that of the extracts. The phytochemical analysis 
revealed the presence of saponin, carbohydrates, tannins, flavonoids and proteins in all the extracts 
while glycoside and alkaloids, were found in some. 
Conclusion: The finding of this result suggest that Pleurotus squarrosulus possess broad-spectrum 
antimicrobial activity. The potential of developing antimicrobials from plants appear rewarding. 
 
 
Keywords: Pleurotus squarrosulus; antimicrobial activities; mushroom; phytochemicals; bacteria; 
yeast. 
 
1. INTRODUCTION 
 
Pleurotus species is one of the choice edible 
mushrooms which can be cultivated in many 
countries in the subtropical and temperate zones. 
Generally Pleurotus is referred to as “oyster 
mushroom” over the world while in China it is 
known as Abalone mushroom‟ and „Dhingri‟ in 
India. Pleurotus species have been used by the 
people in all over the world for their nutritional 
value, medicinal properties and other beneficial 
effects [1].  
 
Oyster mushrooms are easy to grow and process 
and do not need huge investment. Mushroom 
farming is being practiced in more than 100 
countries and its production is increasing at the 
rate of 7 per cent per annum. Production of 
mushroom has already crossed 5 million metric 
tons annually in the world and is expected to 
reach around 7 million metric ton in next ten 
years. India had been known world over for its 
exotic mushrooms and total mushroom 
production in India was 48,000.00 tons in 2005. 
Oyster mushroom cultivation has increased 
during the last decade [2]. 
 
Mushrooms have been used as food supplement 
from times immemorial not only for their flavor, 
aroma and nutritive values but also for their 
medicinal properties [3-5]. Wild mushroom holds 
a variety of bioactive compounds that have made 
it possible to be used as an impending source for 
the improvement of medicine and nutraceuticals 
[6]. 
 
A number of medicinal mushrooms, such as 
Aleurodiscus, Coprinus, Clitocybe, Daedalea, 
Marasmius, Merulius, Pleurotus, Polyporus, 
Poria, Psathyrella, and Tricholoma spp., are rich 
sources of ß-glucan, lectin, phenolic compounds, 
flavonoids, polysaccharides, triterpenoids, diatery 
fibre, lentinan, schizophyllan, lovastatin, pleuran, 
steroids, glycopeptides, terpenes, saponins, 
xanthones, coumarins, alkaloid, purin, purimidin, 
kinon, fenil propanoid, kalvasin, volvotoksin, 
flammutoksin porisin, eryngeolysin etc. [1]. 
 
These bioactive compounds have been 
employed as immune-modulator, anti-fibrotic, 
anti-inflammatory, anti-diabetic, anti-viral, 
antioxidant and antimicrobial agents [7]. Besides, 
mushroom has been used extensively in 
traditional medicine for curing of various types of 
diseases [8-10]. For centuries, mushrooms have 
been prescribed for treatment of diseases such 
as gastro-intestinal disorder, bleeding, high blood 
pressure and various bacterial infections [11]. 
While some of the medicinal values associated 
with mushroom must have arisen from 
surperstitious beliefs and myths, they have 
provided information for curiosity research 
studies. Research has shown that some of these 
claims are not mere myth but are authentic 
[12,13]. Besides medicinal and nutritional use, 
mushroom can be used as natural dyes for 
fabrics [14]. 
 
2. MATERIALS AND METHODS 
 
2.1 Collection and Identification of 
Materials 
 
Pleurotus squarrosulus was collected from 
different sources of Umuahia North Local 
Government area, Abia state and identified by a 
botanist in the Department of botany, University 
of Nigeria, Nsukka. 
 
2.2 Test Organisms Used 
 
Pure cultures of Escherichia coli JCM 20135 and 
Bacillus cereus IFO 13804 were obtained from 
Department of Microbiology, University of Nigeria 
Nsukka while pure cultures of Staphylococcus 
aureus ATCC 25923, Candida albicans ATCC 
10231, Pseudomonas aeruginosa ATCC 25783 
and Candida glabrata ATCC 22018 were 
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obtained from Spectramedics Laboratories No. 2 
Adebayo close, Araromi Offiri Ikenne Road, 
Sagamu, Ogun State. 
 
2.3 Standard Antimicrobials 
 
Tetracycline (5 µg/ml), Amplicillin (5 µg/ml), 
Oxacillin (5 µg/ml) and Nystatin (20 µg/ml) oxoid 
discs were used as positive standards. 
 
2.4 Sample Preparation and Extraction 
 
Fresh Pleurotus squarrosulus mushrooms were 
thoroughly washed with distilled water, cut into 
pieces, air-dried at room temperature and 
pulverized using manual grinder. Fifty grams of 
each of the ground samples was soaked in 500 
ml ethanol, cold water, and methanol for 24 
hours with intermittent shaking. Each sample 
was filtered using Whatman №1 filter paper. The 
filtrate was dried with a rotary evaporator in order 
to obtain the extract which was scooped and 
poured into well-labeled sample bottles and 
stored at 4ºC [15]. 
 
2.5 Inoculum Preparation 
 
Pure cultures of Escherichia coli JCM 20135 and 
Bacillus cereus IFO 13804 were obtained from 
the Department of Microbiology, University of 
Nigeria Nsukka while pure cultures of 
Staphylococcus aureus ATCC 25923, Candida 
albicans ATCC 10231, Pseudomonas 
aeruginosa ATCC 25783 and Candida glabrata 
ATCC 22018were obtained from Spectramedics 
Laboratories, Sagamu, Ogun State, Nigeria. 
Inoculum was prepared by emulsifying overnight 
colonies from an agar medium. A 0.5 McFarland 
standard (equivalent to approximately 108 cfu/ml) 
was used. Media plates were inoculated within 
30 minutes of standardizing the inoculum to 
avoid changes in inoculums density. 
 
2.6 Determination of Antimicrobial 
Activity of Mushroom Extracts 
 
Antimicrobial activity of mushroom extracts was 
determined according to the National Committee 
of Clinical Laboratory Standards [16]. Agar disc 
diffusion method on SDA and Muller-Hinton agar 
were used for fungi and bacteria respectively. A 
micropipette was used to introduce 100 µL of the 
inoculum onto the agar plate, and spread with 
glass rod spreader under sterile conditions. The 
paper discs of 6 mm diameter soaked in 10 µL of 
different concentrations of the extracts (500, 250, 
125, 62.5, 31.25, 15.63 and 7.81 mg/mL) was 
applied on the agar plate. Similarly, for control 
plates, paper discs of 6 mm with dilute 
dimethylsulfoxide were used as negative control 
and antibiotics discs of tetracycline (10 µg/mL) 
and ampicillin (10 µg/mL) were used for Gram 
negative bacteria isolates, oxacillin (5 µg/mL) 
was used for Gram positive bacteria isolates 
whereas antifungi disc of nystatin (20 µg/mL) 
oxoid disc was used as positive control.  
    
This procedure was carried out in triplicate for 
the entire test organisms and allowed to stand for 
30 min on the bench after which they were 
incubated for 24 h at 37 ± 2ºC for bacteria and 
72 at 28 ± 2ºC for yeast. After incubation, the 
inhibition zone diameters produced by the 
different concentrations of the crude extracts 
were measured (in millimeter) using transparent 
meter rule.  
 
2.7 Determination of Minimum Inhibitory 
Concentrations (MICs) of the 
Mushroom Extracts 
 
The MIC of the extracts was determined for the 
test organisms in triplicates at varying 
concentrations (250, 125, 62.5, 31.25, 15.62, 
7.80 and 3.90 mg/ml). To obtain these 
concentrations, 1.0 ml of varying concentrations 
of the extracts with double strength (500, 250, 
125, 62.5, 31.25, 15.62 and 7.80 mg/ml) were 
constituted in different test tubes. About 1.0 ml of 
Mueller-Hinton broth (for bacteria) and 
Sabouraud dextrose broth (for fungi) was added 
and then a loopful of the test organism, 
previously diluted to 0.5 McFarland turbidity 
standard, was introduced. Controls of Mueller-
Hinton broth and Sabouraud dextrose broth 
without the mushroom extract were set up. All 
the bacterial cultures were incubated at 37± 2℃ 
for 24 hours and yeast culture incubated at 
28± 2℃ for 72 hours. After incubation each tube 
was examined for microbial growth. The lowest 
concentration of the extract that inhibited the 
growth of the test organisms as detected by lack 
of visual turbidity was designated the MIC [16]. 
 
2.8 Determination of Minimum 
Bactericidal Concentrations (MBCs) 
and Minimum Fungicidal 
Concentrations (MFCs) of the 
Mushroom Extracts 
 
MBC was determined by selecting tubes that 
showed no bacterial growth during the MIC 
determination. A loopful from each of the tubes 
  
 
 
Kalu and Kenneth; JAMB, 4(3): 1-9, 2017; Article no.JAMB.34644 
 
 
 
4 
 
was sub-cultured on the Mueller Hinton Agar and 
incubated for 24 hours at 37°C ± 2℃. MFC was 
determined by selecting tubes that showed no 
fungal growth during MIC determination. A 
loopful from each of the test tubes was sub-
cultured on Potato Dextrose agar. The plates 
were incubated for 72 hours at 28 ± 2℃ [16]. 
 
2.9 Statistical Analysis 
 
Experimental values were given as means ± 
standard deviation (SD). Statistical significance 
of data were analyzed at P ≤ 0.05 (Independent-
Samples T Test) using statistical package for 
social sciences (SPSS, Armonk, NY, USA) 
version 20. 
 
3. RESULTS AND DISCUSSION 
 
Natural products not only provide valuable 
components but also an important source of 
bioactive compounds that provide lead 
information for developing useful synthetic 
compounds. Mushrooms contain a large number 
of biologically active components that impart 
health benefits and protection against 
degenerative diseases. They have been 
traditionally used in all over world for treatment of 
variety of chronic disease. Antimicrobial activity 
of the crude extract of Pluerotus squarrosulus as 
well as phytochemical characteristics were 
studied. Table 1 shows the result of the MIC and 
MBC of the ethanolic, methanolic and aqueous 
extracts of P. squarrosulus on the test 
organisms. The MIC of ethanolic extract of           
P. squarrosulus showed that B. cereus,              
S. aureus, P. aeruginosa and E.coli, had 15.63, 
15.63, 15.63 and 31.25 mg/ml with MBC of 
15.63, 31.25, 31.25 and 31.25 mg/ml 
respectively. The methanolic extract of P. 
squarrosulus showed that the MIC varied 
between 3.90 and 125 mg/ml with MBC of 7.81 
to 125 mg/ml while the MIC of aqueous extract of 
P. squarrosulus varied between 31.25 and 62.50 
mg/ml with MBC of 31.25 to 125 mg/ml. 
 
Table 2 shows the result of the average MIC and 
MFC of the ethanolic, methanolic and aqueous 
extracts of P. squarrosulus on test organisms. 
The MIC of ethanolic extract of P. squarrosulus 
showed 15.63 mg/ml for C. albicans and 125 
mg/ml for C. glabrata with MFC of 31.25 and 125 
mg/ml, respectively, the MIC of methanolic 
extract of P. squarrosulus showed 250 mg/ml for 
C. albicans while C. glabrata showed no activity 
with MFC of 250 mg/ml for C.albicans while the 
MIC of aqueous extract of P. squarrosulus 
showed 7.81 mg/ml for C. albicans and 62.5 
mg/ml for C. glabrata with MFC of 15.25 and 125 
mg/ml, respectively. 
 
Table 1. The MIC and MBC of crude extract of Pleurotus squarrosulus 
 
Extract Test organism  MIC (mg/ml) MBC (mg/ml) 
 
Ethanol 
B. cereus 15.63 15.63 
S.aureus 15.63 31.25 
P. aeruginosa 15.63 31.25 
E.coli 31.25 31.25 
 
Methanol 
B. cereus 3.90 7.81 
S.aureus 31.25 62.5 
P. aeruginosa 62.5 62.5 
E.coli 125 125 
 
Aqueous 
B. cereus 62.5 125 
S.aureus 31.25 31.25 
P. aeruginosa  ND  ND 
E.coli  ND  ND 
ND = Not determined 
 
Table 2. The MIC and MFC of the crude extract of Pleurotus squarrosulus 
 
Extract Test organism MIC (mg/ml) MFC (mg/ml) 
Ethanol C.albicans 15.63 31.25   
C.glabata 125 125 
Methanol C.albicans 250 250 
C.glabata ND ND 
Aqueous C.albicans 7.81 15.25 
C.glabata 62.5 125 
ND = Not determined 
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Table 3 shows the phytochemical analysis that 
revealed the presence of bioactive compounds 
which were present at varying levels. Saponins, 
protein and carbohydrate were detected in all the 
extracts while glycosides, alkaloids, tannins and 
flavonoids were found in some. 
 
Fig. 1 shows the antimicrobial activity of 
Pleurotus squarrosulus methanol extract on the 
test organisms. The mean inhibition zone 
diameter varied directly with increase in extract 
concentration. E.coli was inhibited at different 
concentration of 500, 250 and 125 mg/ml, P. 
aeruginosa and B. cereus were inhibited at 
different concentration ranging from 500 mg/ml to 
62.5 mg/ml, also S. aureus was inhibited at 
different concentrations ranging from 500 mg/ml 
to 31.25 mg/ml and C. albicans were inhibited at 
different concentrations of 500 mg/ml to 31.25 
mg/ml whereas C. glabrata was not inhibited by 
the extract even at the highest concentration of 
500 mg/ml. However, inhibition of the 
antibacterial and antifungal control for the test 
organisms were significantly higher (p < 0.05) 
than that of the extract. 
 
Fig. 2 presents the antimicrobial activity of 
Pleurotus squarrosulus ethanol extract on the 
test organisms. E. coli, B. cereus, S. aureus and 
C.albicans were well inhibited at different 
concentrations ranging from 500 mg/ml to 31.25 
mg/ml while P. aeruginosa were inhibited at 
concentrations between 500 mg/ml and 62.5 
mg/ml whereas C. glabrata that was only 
 
 
Fig. 1. The antimicrobial activity of Pleurotus squarrosulus methanol extract on the test 
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Fig. 2. The antimicrobial activity of Pleurotus squarrosulus ethanol extract on the test 
organisms 
 
Table 3. Phytochemical analysis of Pleurotus squarrosulus in different solvent 
 
Solvents Methanol Ethanol Aqueous 
Saponin ++ + + 
Tannins + ++ + 
Flavonoid + ++ + 
Alkaloid + + - 
Proteins ++ +++ + + 
Glycosides ++ +++ - 
Carbohydrates ++ ++ ++ 
Legend: - = not present, + = present in low concentration, ++ = moderate, +++ = present in high concentration 
 
inhibited at concentrations of 500 mg/ml and 250 
mg/ml. However, inhibition of the antibacterial 
and antifungal control for the test organisms 
were significantly higher (p < 0.05) than that of 
the extract. 
 
Fig. 3 shows the result obtained for the 
antimicrobial activity of Pleurotus squarrosulus 
aqueous extract. B. cereus, S. aureus, C. 
albicans and C. glabrata were well inhibited               
by the extract at concentrations ranging from  
500 to 125 mg/ml. E. coli and P. aeruginosa  
were not inhibited even at the highest 
concentration of 500 mg/ml. However,             
inhibition of the antibacterial and antifungal 
control for the test organisms were significantly 
higher (p < 0.05) than that of the extract. 
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Fig. 3. The antimicrobial activity of Pleurotus squarrosulus aqueous extract on the test 
organisms 
 
The results indicated that extracts from 
mushroom has similar antimicrobial properties as 
reported by Nwachukwu and Uzoeto [15]. The 
sensitivity of isolates to the mushroom extracts 
implies that intrinsic substance in the extracts is 
unknown to the microorganisms which made it 
impossible for them to resist. The variations in 
the antimicrobial activities of Pleurotus 
squarrosulus extracts may be due to the 
differences in their bioactive compositions or 
concentrations, methods of extraction and 
mechanism of action of active ingredients [17]. 
The results of the present study strengthened the 
outcomes of earlier works done by others that 
showed mushrooms produced a great variety of 
antimicrobial agents. For instance, it is known 
that the extract from fruit bodies of several 
Lactarius sp. [18,19]; Fomitopsis sp. [20]; Boletus 
sp. [21]; Cortinarius sp. [22]; Ganoderma 
lucidum, Navesporus floccosa and Phellinus 
rimosus [23]; Pleurotus tuber-regium [24]; 
Amanita caesarae, Armillaria mellea, 
Chroogomphus rutilus, Clavariadelphus 
truncates, Clitocybe geotropa, Ganoderma sp., 
Ganoderma carnosum, Hydnum repandum, 
Hygrophorus agathosmus, Lenzites betulina, 
Leucoagaricus pudicus, Paxillus involutus, 
Polyporus arcularius, Rhizopogon roseo, 
Sarcodon imbricatus, Suillus collitinus, Trametes 
versicolor, Tricholoma auratum, Tricholoma 
fracticum [25]; Lactarius deliciosus, Sarcodon 
imbricatus and Tricholoma portentosum [26]; 
Russula delica [27]; Pleurotus eryngii var. ferulae 
[28]; Infundibulicybe geotropa, Lactarius 
controversus, Lactarius delicious and Phellinus 
hartigii [29]; Lactarius indigo [30] and Stereum 
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ostrea [31] contain a wide range of antimicrobial 
activity. 
 
4. CONCLUSION 
 
This research has further illuminated the 
medicinal value of Pleurotus squarrosulus found 
in Umuahia North Local Government, Abia State 
Nigeria. From the present study, the sensitivity of 
isolates to the mushroom extracts implies that 
intrinsic substance in the extracts is unknown to 
the microrganisms, which made it impossible for 
them to resist. 
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